ÂÜÀòÂÒÂ×

Simon Feldbæk Nielsen's work experience includes various roles and positions in the pharmaceutical and biotech industries. Simon is currently serving as the Chief Technology Officer (Head of R&D) at Draupnir Bio since November 2022. Prior to this, they worked as an Entrepreneur In Residence (EiR) at Novo Seeds (Biorigin.dk) starting from January 2022.

In 2015, Simon joined Innovation Fund Denmark as an Investment panel member (InnoBooster). Simon also had a significant tenure at LEO Pharma A/S, starting in 2003, where they held multiple senior positions such as Senior Director, Executive Director, Director, Chemical Research, and R&D Project Manager.

Before joining LEO Pharma A/S, Simon worked at Lica Pharmacuticals from 2000 to 2003, where they served as the Director of Medicinal Chemistry and also co-founded the company. Lica Pharmaceuticals focused on developing and commercializing compounds for the treatment of bacterial and parasitic diseases.

Simon's career began in 1997 at NeuroSearch, where they worked as a Medicinal Chemist and Project Manager until 2000.

Overall, Simon Feldbæk Nielsen has amassed extensive experience in various leadership and research positions within the pharmaceutical and biotech sectors, demonstrating their expertise and commitment to advancing the field.

Simon Feldbæk Nielsen has a diverse educational background in the field of pharmaceutical medicine and antiparasitic chalcones. In 1985, they completed their high school education at Fredriksværk Amtsgymnasium. Following this, from 1988 to 1993, they pursued a Bachelor's degree in Pharmacy, receiving an M.Sc. (Pharm) from Københavns Universitet - University of Copenhagen. In 1994, they enrolled in a Ph.D. program at the same university, specializing in Antiparasitic Chalcones. During this period, from 1996 to 1996, they also conducted a research visit at Università degli Studi di Perugia. After completing their Ph.D., they furthered their knowledge in pharmaceutical medicine by obtaining a Certificate in Pharmaceutical Medicine from the University of Basel, specifically in the European Course in Pharmaceutical Medicine (ECPM) program from 2009 to 2011.